IKVAV PA promotes regeneration of motor axons after SCI. a, b, Representative Neurolucida tracings of BDA-labeled descending motorfibers within a distance of 500 µm rostral ofthe lesion in vehicle-injected (a) and IKVAV PA-injected (b) animals. The dotted lines demarcate the borders of the lesion. c–f, Bright-field images of BDA-labeled tracts in lesion (c, e) and caudal to lesion (d, f) used for Neurolucida tracings in an IKVAV PA-injected spinal cord (a, b).g, h, Bar graphs show the extent to which labeled corticospinal axons penetrated the lesion. *The groups representing three control and three IKVAV PA mice and the tracing of 130 individual axons differfrom each other at p < 0.03 by the Wilcoxon ranktest. R, Rostral; C, caudal; D, dorsal; V, ventral. Scale bars: a–d, 100 µm; e–f , 25 µm